a76df2f9_docrine_Cancer_Research___CFCF__Status
[Title] A Phase I-II Study Evaluating the Maximum Tolerated Dose, Dosimetry, Safety, and Efficacy of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma [Phase] I/II [Conditions] Pheochromocytoma [State] IA MD MI MO NY NC PA RI [Status] 
Not Recruiting
N o t R e c r u i t i n g
E n r o l l i n g
Clinical Trials Finder | Carcinoid and Pancreatic Neuroendocrine Cancer Research | CFCF
Status